Clinical Trials Sponsored by Etubics Corporation

Total 6470 results

Exsulin Corporation

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

Diabetes Mellitus, Non-Insulin-Dependent

United States
Exsulin Corporation

Completed

Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

Diabetes Mellitus, Insulin-Dependent

United States
Yuhan Corporation

Completed

Investigate the Safety/Tolerability and Efficacy of Bilastine 20mg in Korean Patients With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Korea, Republic of
Yuhan Corporation

Completed

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

Non-erosive Reflux Disease

Korea, Republic of
Yuhan Corporation

Completed

Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

Healthy

Korea, Republic of
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects

Healthy

Korea, Republic of
Erchonia Corporation

Terminated

Study of Low Level Laser Therapy and Tinnitus Relief

Tinnitus

United States
Erchonia Corporation

Completed

Study of Low Level Laser Therapy to Treat Chronic Heel Pain Arising From Plantar Fasciitis

Plantar Fasciitis

United States
Erchonia Corporation

Completed

Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference

Body Contouring
Erchonia Corporation

Completed

Low Level Laser Light Therapy and Chronic Neck and Shoulder Pain

Musculoskeletal Pain | Neck Pain | Shoulder Pain | Musculoskeletal Strain | Musculoskeletal Sprain
Histogenics Corporation

Completed

NeoCart Phase 2 Clinical Trial

Articular Cartilage Damage

United States
Erchonia Corporation

Completed

Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery

Pain
Yuhan Corporation

Completed

YH4808 Postprandial PK/PD Study in Healthy Subjects

Healthy

Korea, Republic of
Exsulin Corporation

Terminated

Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

Type 1 Diabetes Mellitus

United States, Canada
Cordis Corporation

Unknown

CYPRESS - CYPHER for Evaluating Sustained Safety

Coronary Artery Disease

United States
Amorepacific Corporation

Completed

Cumulative Irritation Test of PAC-14028 in Healthy Volunteers

Healthy

Korea, Republic of
Amorepacific Corporation

Completed

PAC-14028 in Healthy Male Volunteers

Healthy

Korea, Republic of
Mannkind Corporation

Completed

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, United States, Austria, United Kingdom
Yuhan Corporation

Completed

A Randomized, Open-label, Multiple-dose, Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan in Healthy Volunteer (YH16410 DDI)

Healthy Volunteer

Korea, Republic of
Yuhan Corporation

Completed

PK Study of Telmisartan/Rosuvastatin FDC Compared to Combination of Telmisartan and Rosuvastatin

Dyslipidemia & Hypertension

Korea, Republic of
Vidacare Corporation

Completed

Healthy Adult Volunteer Study of Intraosseous Infusion Using the Sternum

Intraosseous Vascular Access

United States
Quidel Corporation

Completed

Sofia hCG FIA Field Study

Pregnancy, Early Detection

United States
Quidel Corporation

Completed

Strep A Fluorescent Immunoassay and Analyzer Field Study

Strep Throat

United States
Vidacare Corporation

Terminated

Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.

Airway Control

United States
Adimmune Corporation

Completed

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old

Influenza
Incyte Corporation

Terminated

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
NeuroVista Corporation

Terminated

Seizure Advisory System Feasibility Study

Epilepsy

Australia
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Yuhan Corporation

Completed

Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects

Healthy

Korea, Republic of
Adimmune Corporation

Completed

Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects

Influenza

Taiwan
Vidacare Corporation

Completed

Observation of Intraosseous Vascular Access in the Emergency Department

Patients Requiring Urgent Vascular Access

United States
Mannkind Corporation

Completed

Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin

Healthy
Mannkind Corporation

Completed

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Diabetes Mellitus | Asthma

United Kingdom
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Hypertension | Hyperlipidemia

Korea, Republic of
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Mannkind Corporation

Terminated

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Stage IV Melanoma | Stage III Melanoma

United States
Cordis Corporation

Completed

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU (ECLIPSE)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Revalesio Corporation

Completed

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Myocardial Infarct

United States
VaxInnate Corporation

Completed

Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults

Influenza

United States
Seikagaku Corporation

Completed

Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Yuhan Corporation

Completed

Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects

Healthy

Korea, Republic of
EpiCept Corporation

Completed

A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

Neuropathy | Nerve Pain | Post Herpetic Neuralgia | PHN

India
VIRxSYS Corporation

Active, not recruiting

A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial (Rollover)

HIV Infections

United States
Cordis Corporation

Terminated

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

Coronary Artery Disease
Magnetecs Corporation

Unknown

Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping (RICTAM)

Tachycardia, Ventricular | Tachycardia, Supraventricular

Spain
AmpliMed Corporation

Completed

Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Guidant Corporation

Completed

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

Acute Myocardial Infarction

Netherlands
Guidant Corporation

Completed

Long Term Integrity Follow-up Evaluation (LEAD LIFE)

Sudden Cardiac Death
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Advanced Melanoma | Stage III and IV Melanoma

United States

3

Subscribe